A composite endpoint for systemic sclerosis-associated interstitial lung disease: association with mortality in two clinical trial cohorts

By afschroeder • November 29, 2025

Volkmann ER, Wilhalme H, Good S, Kim GHJ, Goldin J, Roth MD, Tashkin DP. A composite endpoint for systemic sclerosis-associated interstitial lung disease: association with mortality in two clinical trial cohorts. Respir Res. 2025 Nov 28;26(1):337. doi: 10.1186/s12931-025-03401-8. PMID: 41316297; PMCID: PMC12661867.

Tags: DOM STAT, General Internal Medicine, interstitial lung disease, Patient Outcome Assessment, Publications, Pulmonary, Critical Care & Sleep Medicine, Randomized Controlled Trial, Rheumatology, systemic sclerosis

Is Cardiovascular Mortality Among People with Epilepsy increasing? A retrospective US population study

Curtis A, Markovic D, Liao A, Ganapa S, Gaertner M, DeGiorgio CM. Is Cardiovascular Mortality Among People with Epilepsy increasing? A retrospective US population study.[...]

Career Choices of Ambulatory Chief Residents: A 20-year, multicenter study

Cornia PB, Starks H, Harrington WE, Akwe J, Allaudeen N, Boggan JC, Carlson MA, Chun J, Cox L, Ehlers E, Alshaeba SE, Elzweig J, Fletcher[...]

Pain Scores and Opioid Consumption after Robotic-assisted Abdominal Surgery: A Single Centre Historical Cohort Study

Nourian MM, Wingert T, Delaporte A, Grogan T, Alexander B, Boulos NM, Rahman S, Naim N, Antongiorgi ZD, Moon J, Kasanjian K, Rodriguez-Triana V, Chamie[...]